Senolytic Treatment Improve Small Intestine Regeneration in Aging

Area of Science:

• Gerontology
• Gastroenterology
• Cellular Senescence

Background:

• Aging leads to decreased intestinal villi and crypts, impairing nutrient absorption.
• Cellular senescence contributes to age-related functional decline in various tissues, including the gut.

Purpose of the Study:

• To investigate the senolytic combination of dasatinib and quercetin (D+Q) for its effects on the aging intestinal tract.
• To assess D+Q's impact on intestinal structure, cellular senescence markers, and nitric oxide production in aged mice.

Main Methods:

• Administration of a senolytic combination (D+Q) to elderly mice.
• Analysis of intestinal villi and crypt morphology.
• Assessment of senescence markers (p21, p16, Ki67) and apoptotic cells.
• Measurement of nitric oxide (NO) levels.

Main Results:

• D+Q treatment reduced expression of senescence markers (p21, p16, Ki67) and apoptotic cells.
• Significant increase in villi height and crypt number observed post-D+Q treatment.
• Enhanced nitric oxide (NO) production in aged mice following D+Q administration.

Conclusions:

• D+Q therapy effectively alleviates age-related intestinal senescence in mice.
• This senolytic approach shows potential for improving intestinal function and structure in aging populations.
• The study provides a model for evaluating interventions against gut aging.